背景:纳米技术,连接材料科学和生物学的领域,探索各种应用。银纳米粒子,范围从1nm到100nm,通常被标记为“银”,尽管由于表面上银原子的比例与本体相比提高了,一些含有大量的氧化银。该特性确立了银作为突出的纳米颗粒材料。Stevia,因其叶子的甜味和所谓的治疗品质而受到重视,在南美已经使用了几个世纪,既可以作为天然甜味剂,也可以用于传统的健康疗法。这项研究的目的是评估罗勒和甜叶菊介导的银纳米颗粒的抗炎和抗氧化活性。
方法:采用的方法涉及使用牛血清白蛋白(BSA)测定法评估抗炎作用和使用2,2-二苯基-1-吡啶酰肼(DPPH)测定法评估抗氧化作用,具有不同的浓度(10微升,20微升,30微升,40微升,和50微升)的纳米颗粒。
结果:结果表明,纳米颗粒的抗炎特性超过标准值,浓度为10µL,20微升,和30微升,而抗氧化性能在等浓度下也明显超过标准值。最大抑制百分比为10μL(72.5%)。
结论:银纳米颗粒,用罗勒和甜叶菊提取物强化,作为有效的抗炎和抗氧化剂,表明它们作为市售产品替代品的可行性。
BACKGROUND: Nanotechnology, a field bridging material science and biology, explores various applications. Silver nanoparticles, ranging from 1 nm to 100 nm, are commonly labeled as \"silver,\" although some contain a substantial quantity of silver oxide owing to the heightened ratio of silver atoms on the surface compared to the bulk. This characteristic establishes silver as a prominent nanoparticulate material. Stevia, valued for its leaf\'s sweetness and purported therapeutic qualities, has been utilized for centuries in South America functioning both as a natural sweetener and in traditional health remedies. The objective of this study was to evaluate the anti-inflammatory and antioxidant activity of Ocimum tenuiflorum- and Stevia rebaudiana-mediated silver nanoparticles.
METHODS: The methods employed involved evaluating the anti-inflammatory effects using the bovine serum albumin (BSA) assay and antioxidant effects using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, with varying concentrations (10 µL, 20 µL, 30 µL, 40 µL, and 50 µL) of the nanoparticles.
RESULTS: The results indicated that the anti-inflammatory properties of the nanoparticles surpassed standard values at concentrations of 10 µL, 20 µL, and 30 µL, while the antioxidant properties were also notably surpassing standard values at equivalent concentrations. The maximum inhibition percentage was noted with 10 µL (72.5%).
CONCLUSIONS: The silver nanoparticles, fortified with extracts from Ocimum tenuiflorum and Stevia rebaudiana, exhibited a promising potential as effective anti-inflammatory and antioxidant agents, suggesting their viability as alternatives to commercially available products.